Price of diabetes medicines slashes down
Posted on: 25/Oct/2016 6:37:33 PM
There is dip in price of diabetes drugs in the past nine months. The price has almost halved, relieving the millions of diabetics in India.
New range of medicines of gliptin family have lessened the drug prices in lesser than a year. There are over 68 million diabetics in India of which 1.85 million off them are on gliptin therapy to cope with their type 2 diabetes.
A pack of this medicine was priced Rs 156 in January and this has come down to Rs 79 as of September - thanks to domestic companies. The average daily price of these diabetes drugs is Rs 45 while the other medicines including teneligliptin based drugs are of the range Rs 5 to 7 launched last year.
Under brands Ziten and Zita Plus, Glenmark had launched the medicine for Rs 19.90 per tablet while the other gliptins were of the range Rs 45.
Now, over thirty companies including Mankind Pharma, Glenmark, Zydus, Eris Life Sciences and Intas are producing over 34 brands of the drug from teneligliptin molecule.
Most of the gliptins are imported and only teneligliptin is manufactured in India. With this launch, the cost of gliptin therapy has drastically reduced, says Glenn Saldanha, Chairman of Glenmark Pharmaceuticals.
